Riskpilot← Back to searchSign inGet full accessAlfasigma Denmark ApS
APSActiveCVR 42447242Sundkrogsgade 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20215 employees
Revenue 2024
DKK 9,5M
-19% vs 2023
EBITDA margin
13.6%
-27% vs 2023
Equity ratio
27.4%
Financial strength
Net profit 2024
DKK 815K
-41% vs 2023
| Revenue | DKK 9,5M | -19% |
| EBITDA | DKK 1,3M | -27% |
| Net profit | DKK 815K | -41% |
| Total assets | DKK 14,9M | +105% |
| Equity | DKK 4,1M | +25% |
| Employees | 5 | — |
Legal name
Alfasigma Denmark ApS
CVR number
42447242
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. juni 2021
Share capital
DKK 40.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede direktion.
Company purpose
Selskabets formål er at drive virksomhed inden for kommercialisering af farmaceutiske produkter samt aktiviteter, der efter direktionens skøn er forbundet hermed.
Address
Sundkrogsgade 21
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 5.081 | 13.809 | 11.778 | 9.532 |
| Staff expenses | -4.558 | -11.917 | -10.002 | -8.238 |
| EBITDA | 523 | 1.892 | 1.776 | 1.294 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 523 | 1.892 | 1.776 | 1.294 |
| Net financials | -12 | -38 | 7 | -243 |
| Profit before tax | 511 | 1.854 | 1.783 | 1.051 |
| Tax | 112 | 408 | 393 | 236 |
| Net profit | 398 | 1.446 | 1.390 | 815 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 9.588 | 17.049 | 7.284 | 14.902 |
| Equity | 438 | 1.884 | 3.274 | 4.089 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 9.150 | 15.164 | 4.011 | 10.813 |
| Total debt | 9.150 | 15.164 | 4.011 | 10.813 |
EBITDA margin
13.6%
This company
15.8%
Market median
-14% vs market
20212024
Equity ratio
27.4%
This company
38.2%
Market median
-28% vs market
20212024
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20212024
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20212024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20212024
Debt / equity
2.64×
This company
0.62×
Market median
-326% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-06-03 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SO Management | Management | 2024 | — | — |
AA Management | Management | 2025 | — | — |
GN Founder | Founder | 2021 | — | — |
MC Management | Management | 2024 | — | — |
BF Management | Management | 2021 | — | — |
Ld Management | Management | 2025 | — | — |
MG Management | Management | 2026 | — | — |
MM Management | Management | 2021 | — | — |
AB Management | Management | 2026 | — | — |
Md Management | Management | 2021 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alfasigma Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Samara Orsatti | Management | 0 companies |
| Alberto Avaltron | Management | 0 companies |
| Galapagos NV | Founder | 0 companies |
| Maria Chiara Cucchi | Management | 0 companies |
| Bart Filius | Management | 0 companies |
| Line de Linde Henriksen | Management | 0 companies |
| Massimo Giorgio Visentin | Management | 0 companies |
| Michele Manto | Management | 0 companies |
| Alessio Battaglia | Management | 0 companies |
| Marcel de Jong | Management | 0 companies |